D-0110-2018 Class III Terminated

Recalled by Osmotica Pharmaceutical Corp — Marietta, GA

FDA drug recall D-0110-2018 was initiated by Osmotica Pharmaceutical Corp on Dec 18, 2017 and is designated Class III. Reason for recall: Subpotent Drug The recall status is terminated (terminated May 1, 2019). Affected quantity: 10064 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 27, 2017
Initiation Date
Dec 18, 2017
Termination Date
May 1, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10064 bottles

Product description

Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg, 100-count bottles, Rx Only, Trigen Laboratories, LLC. Bridgewater, NJ 08807, NDC 13811-707-10

Reason for recall

Subpotent Drug

Distribution pattern

Nationwide

Code information

Lot #: 170027A, Exp. 02/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0110-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0110-2018. Report a data issue: hello@regdatalab.com.